ABSTRACT
The hepatopulmonary syndrome (HPS) is a common pulmonary vascular complication in patients with liver disease. Its pathophysiology leads to the development of vasodilatation and angiogenesis in gas exchange regions with or without resulting hypoxemia. HPS is associated with increased mortality in cirrhotic patients, and the only known cure is liver transplantation.
